S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

LPTX Leap Therapeutics Inc

0.5117

-0.026 (-4.84%)

Last Updated: 13:29:31

Delayed by 15 minutes

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Leap Therapeutics (NASDAQ:LPTX)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Leap Therapeutics Charts.

Leap Therapeutics (NASDAQ:LPTX)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Leap Therapeutics Charts.

Leap Therapeutics Inc News

Form 8-K - Current report
Tuesday 28 January 2025 (1 week ago) • Edgar (US Regulatory)

Leap Therapeutics Reports Initial Clinical Data from Part B of the DeFianCe Study and Part C of the DisTinGuish Study
Tuesday 28 January 2025 (1 week ago) • PR Newswire (US)

Leap Therapeutics to Participate at the 43rd Annual J.P. Morgan Healthcare Conference
Monday 6 January 2025 (1 month ago) • PR Newswire (US)

Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare Conference
Tuesday 26 November 2024 (2 months ago) • PR Newswire (US)

Form 8-K - Current report
Wednesday 13 November 2024 (3 months ago) • Edgar (US Regulatory)

Leap Therapeutics Reports Third Quarter 2024 Financial Results
Wednesday 13 November 2024 (3 months ago) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (3 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Wednesday 6 November 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Thursday 31 October 2024 (3 months ago) • Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Thursday 31 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 4 October 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 4 October 2024 (4 months ago) • Edgar (US Regulatory)

More Leap Therapeutics Inc News Articles

TransCode Therapeutics

RespireRx Pharmaceuticals (CE)

Decentral Life (PK)

Intergrated Cannabis Sol... (PK)

MineralRite (PK)

Kraig Biocraft Laborator... (QB)

Asia Broadband (PK)

Elite Pharmaceuticals (QB)

Bioelectronics (PK)

North Bay Resources (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions